![Damian Lamb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Damian Lamb
Fondateur chez
Genesys Capital Partners, Inc.
Profil
Mr. Lamb is co-Founder and Managing Director of Genesys Capital.
With over 20 years experience in life sciences venture capital, he is one of Canada’s most experienced investors and company builders.
Since co-founding Genesys Capital in 2000, Mr. Lamb has been instrumental in raising over $300 million in venture capital funds, and has been involved in deploying over $250 million across 38 investments.
He currently serves on the Boards of Flosonics Medical and the Centre for Probe Development and Commercialization at McMaster University.
Mr. Lamb has served on the Board of Affinium Pharmaceuticals (acquired by Debiopharm), Ionalytics Corporation (acquired by Thermo Electron Corp.), Millenium Biologix (acquired by Medtronic) and was Chairman of the Board of Fusion Pharmaceuticals Inc., Profound Medical Corp.
and DELEX Therapeutics Inc. when it was sold to YM BioSciences (now Gilead).
Mr. Lamb works closely with Genesys investee companies to strategically position the companies to build value for shareholders.
Prior to co-founding Genesys Capital, Mr. Lamb was an Investment Manager with MDS Capital Corp.
He is a frequently invited speaker at biotechnology industry conferences.
Mr. Lamb graduated from McMaster University, Faculty of Health Sciences, with a Master of Science in Molecular Neurobiology and also holds an MBA from Queen’s University.
Postes actifs de Damian Lamb
| Sociétés | Poste | Début |
|---|---|---|
Genesys Capital Partners, Inc.
 Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital invests in companies located in Canada. The firm focuses on sectors such as biotechnology, pharmaceuticals and medical technology. It participates in early stage capital transactions. | Fondateur | 28/12/2010 |
Flosonics Medical
 Flosonics Medical Packaged SoftwareTechnology Services Develops and operates software platform for medical | Directeur/Membre du Conseil | - |
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Damian Lamb
| Sociétés | Poste | Fin |
|---|---|---|
| FUSN PHAR | Président | 02/11/2020 |
| PROFOUND MEDICAL CORP. | Président | 13/06/2019 |
Millenium Biologix Corp.
 Millenium Biologix Corp. BiotechnologyHealth Technology Develops vaccine and skeletal tissue regeneration products | Directeur/Membre du Conseil | 08/05/2007 |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | 31/12/1999 |
The Health Technology Exchange
 The Health Technology Exchange Financial ConglomeratesFinance Provides non-dilutive project financing to the medical and assistive technology sector | Directeur/Membre du Conseil | - |
Formation de Damian Lamb
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Millenium Biologix Corp.
Millenium Biologix Corp. BiotechnologyHealth Technology Develops vaccine and skeletal tissue regeneration products | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital invests in companies located in Canada. The firm focuses on sectors such as biotechnology, pharmaceuticals and medical technology. It participates in early stage capital transactions. | Finance |
Queen's University of Belfast
 Queen's University of Belfast Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DELEX Therapeutics, Inc.
 DELEX Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops inhalation pain treatment products for cancer patients | Health Technology |
Affinium Pharmaceuticals Ltd.
 Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides clinical development of antibacterial | Health Technology |
Ionalytics Corp.
 Ionalytics Corp. Industrial MachineryProducer Manufacturing Designs and manufactures ion-filtering equipment and related engineering instruments | Producer Manufacturing |
Profound Medical, Inc.
 Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Health Technology |
The Health Technology Exchange
The Health Technology Exchange Financial ConglomeratesFinance Provides non-dilutive project financing to the medical and assistive technology sector | Finance |
Profound Medical Corp.
 Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
Flosonics Medical
Flosonics Medical Packaged SoftwareTechnology Services Develops and operates software platform for medical | Technology Services |
